Home > Compound List > Compound details
139264-17-8 molecular structure
click picture or here to close

(4S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one

ChemBase ID: 72776
Molecular Formular: C16H21N3O2
Molecular Mass: 287.35684
Monoisotopic Mass: 287.16337693
SMILES and InChIs

SMILES:
c1c(ccc2c1c(c[nH]2)CCN(C)C)C[C@@H]1NC(=O)OC1
Canonical SMILES:
CN(CCc1c[nH]c2c1cc(C[C@H]1COC(=O)N1)cc2)C
InChI:
InChI=1S/C16H21N3O2/c1-19(2)6-5-12-9-17-15-4-3-11(8-14(12)15)7-13-10-21-16(20)18-13/h3-4,8-9,13,17H,5-7,10H2,1-2H3,(H,18,20)/t13-/m0/s1
InChIKey:
ULSDMUVEXKOYBU-ZDUSSCGKSA-N

Cite this record

CBID:72776 http://www.chembase.cn/molecule-72776.html

Collapse All Expand All

NAMES AND DATABASE IDS

NAMES AND DATABASE IDS

Names Database IDs
IUPAC name
(4S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one
IUPAC Traditional name
zomig
Synonyms
Zomig
Zomigon
AscoTopand
Zomigoro
Zolmitriptan
CAS Number
139264-17-8
PubChem SID
162037697
PubChem CID
60857

DATA SOURCES

DATA SOURCES

All Sources Commercial Sources Non-commercial Sources
Data Source Data ID Price
Selleck Chemicals
S1649 external link Add to cart Please log in.
Data Source Data ID
PubChem 60857 external link

CALCULATED PROPERTIES

CALCULATED PROPERTIES

JChem
Acid pKa 13.002183  H Acceptors
H Donor LogD (pH = 5.5) -1.3495891 
LogD (pH = 7.4) -0.08771248  Log P 2.0428753 
Molar Refractivity 82.4392 cm3 Polarizability 32.885002 Å3
Polar Surface Area 57.36 Å2 Rotatable Bonds
Lipinski's Rule of Five true 

PROPERTIES

PROPERTIES

Safety Information Product Information Bioassay(PubChem)
Storage Condition
-20°C expand Show data source
Salt Data
Free Base expand Show data source

DETAILS

DETAILS

Selleck Chemicals Selleck Chemicals
Selleck Chemicals - S1649 external link
Research Area: Neurological Disease
Biological Activity:
Zolmitriptan(Zomig) is a selective serotonin receptor agonist. It is a triptan, used in the acute treatment of migraine attacks with or without aura and cluster headaches. Cytochrome 1A2 is likely to be the isoenzyme responsible for the metabolism of zolmitriptan. The increased exposure to zolmitriptan and 183C91 by cimetidine indicated that a reduction in the total daily recommended dose of zolmitriptan may be necessary when treating migraine patients who are taking nonspecific cytochrome P450 inhibitors or specific cytochrome 1A2 inhibitors. [1][2]

REFERENCES

REFERENCES

From Suppliers Google Scholar IconGoogle Scholar PubMed iconPubMed Google Books IconGoogle Books
  • • http://en.wikipedia.org/wiki/Zolmitriptan
  • Searching...Please wait...

PATENTS

PATENTS

PubChem iconPubChem Patent Google Patent Search IconGoogle Patent

INTERNET

INTERNET

Baidu iconBaidu google iconGoogle